Epidermal growth factor receptor (EGFR) serves as a key regulator in orchestrating the balance between immunosuppressive and immunostimulatory responses within the TME, particularly in inflammatory breast cancer [93]. Here, EGFR is linked to inflammatory breast carcinoma.